JP2004525618A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525618A5
JP2004525618A5 JP2002555104A JP2002555104A JP2004525618A5 JP 2004525618 A5 JP2004525618 A5 JP 2004525618A5 JP 2002555104 A JP2002555104 A JP 2002555104A JP 2002555104 A JP2002555104 A JP 2002555104A JP 2004525618 A5 JP2004525618 A5 JP 2004525618A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
cell
mrna
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002555104A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525618A (ja
Filing date
Publication date
Priority claimed from US09/756,096 external-priority patent/US20030077754A1/en
Priority claimed from US09/756,097 external-priority patent/US20060088938A1/en
Priority claimed from US09/756,095 external-priority patent/US20020115207A1/en
Priority claimed from US09/838,858 external-priority patent/US20030148937A1/en
Priority claimed from US09/941,492 external-priority patent/US20030027250A1/en
Application filed filed Critical
Priority claimed from PCT/US2002/000416 external-priority patent/WO2002053581A2/en
Publication of JP2004525618A publication Critical patent/JP2004525618A/ja
Publication of JP2004525618A5 publication Critical patent/JP2004525618A5/ja
Pending legal-status Critical Current

Links

Images

JP2002555104A 2001-01-08 2002-01-08 スプライセオソームにより媒介されるｒｎａトランススプライシング Pending JP2004525618A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/756,096 US20030077754A1 (en) 1995-12-15 2001-01-08 Methods and compositions for use in spliceosome mediated RNA trans-splicing
US09/756,097 US20060088938A1 (en) 1995-12-15 2001-01-08 Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants
US09/756,095 US20020115207A1 (en) 1995-12-15 2001-01-08 Methods and compositions for use in spliceosome mediated RNA trans-splicing
US09/838,858 US20030148937A1 (en) 1995-12-15 2001-04-20 Methods and compositions for use in spliceosome mediated RNA trans-splicing
US09/941,492 US20030027250A1 (en) 1995-12-15 2001-08-29 Methods and compositions for use in spliceosome mediated RNA trans-splicing
PCT/US2002/000416 WO2002053581A2 (en) 2001-01-08 2002-01-08 Spliceosome mediated rna trans-splicing

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2005003076A Division JP2005176849A (ja) 2001-01-08 2005-01-07 スプライセオソームにより媒介されるｒｎａトランススプライシング
JP2005003107A Division JP2005168509A (ja) 2001-01-08 2005-01-07 スプライセオソームにより媒介されるｒｎａトランススプライシング

Publications (2)

Publication Number Publication Date
JP2004525618A JP2004525618A (ja) 2004-08-26
JP2004525618A5 true JP2004525618A5 (enExample) 2006-01-05

Family

ID=27542170

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002555104A Pending JP2004525618A (ja) 2001-01-08 2002-01-08 スプライセオソームにより媒介されるｒｎａトランススプライシング
JP2005003076A Pending JP2005176849A (ja) 2001-01-08 2005-01-07 スプライセオソームにより媒介されるｒｎａトランススプライシング
JP2005003107A Pending JP2005168509A (ja) 2001-01-08 2005-01-07 スプライセオソームにより媒介されるｒｎａトランススプライシング

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2005003076A Pending JP2005176849A (ja) 2001-01-08 2005-01-07 スプライセオソームにより媒介されるｒｎａトランススプライシング
JP2005003107A Pending JP2005168509A (ja) 2001-01-08 2005-01-07 スプライセオソームにより媒介されるｒｎａトランススプライシング

Country Status (6)

Country Link
EP (1) EP1358203A4 (enExample)
JP (3) JP2004525618A (enExample)
AU (1) AU2002246959B2 (enExample)
CA (1) CA2434118A1 (enExample)
IL (3) IL165056A0 (enExample)
WO (1) WO2002053581A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10139492B4 (de) * 2001-08-13 2004-06-09 Eul, Joachim, Dr. Verfahren zur Reparatur einer mutierten RNA aus einer gendefekten DNA und zum gezielten Abtöten von Tumorzellen durch RNA-Transspleißen sowie Verfahren zum Nachweis von natürlich-transgespleißter zellulärer RNA
WO2003104412A2 (en) 2002-06-05 2003-12-18 Intronn, Inc. Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
CA2553828A1 (en) * 2004-01-23 2005-08-04 Intronn, Inc. Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
US7879321B2 (en) * 2004-10-08 2011-02-01 Virxsys Corporation Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
JP5017118B2 (ja) * 2004-10-08 2012-09-05 バークシス コーポレーション 組換えタンパク質をインビボ生産するための、非常に豊富な転写産物の標的化トランススプライシング
JP5081462B2 (ja) * 2007-02-02 2012-11-28 富士フイルム株式会社 トランススプライシング法による融合タンパク質作製方法
HK1199285A1 (en) * 2011-08-12 2015-06-26 Virxsys Corporation Compositions and methods for inducing apoptosis
PL3164492T3 (pl) * 2014-07-03 2020-04-30 F. Hoffmann-La Roche Ag Układy ekspresji polipeptydu
EP4217010A4 (en) * 2020-09-28 2025-01-08 Tacit Therapeutics, Inc. TRANS-SPLICING SYSTEM FOR TISSUE-SPECIFIC REPLACEMENT OF RNA SEQUENCES
WO2022220968A1 (en) * 2021-04-15 2022-10-20 U1 Bio, Inc. High efficiency trans-splicing for replacement of targeted rna sequences in human cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0883344B2 (en) * 1995-12-15 2010-06-09 VIRxSYS Corporation Therapeutic molecules generated by trans-splicing
US6280978B1 (en) * 1995-12-15 2001-08-28 Intronn Holdings, Llc Methods and compositions for use in spliceosome mediated RNA trans-splicing

Similar Documents

Publication Publication Date Title
Yi et al. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo
JP2004504001A5 (enExample)
Singh et al. The clothes make the mRNA: past and present trends in mRNP fashion
Plosky et al. Switching from high-fidelity replicases to low-fidelity lesion-bypass polymerases
Kindgren et al. Predictable alteration of sequence recognition by RNA editing factors from Arabidopsis
Florence et al. Ftz-F1 is a cofactor in Ftz activation of the Drosophila engrailed gene
Ruff et al. Enhanced functional potential of nucleic acid aptamer libraries patterned to increase secondary structure
Grainge et al. Activation of XerCD-dif recombination by the FtsK DNA translocase
Zechner et al. Relaxases and plasmid transfer in gram-negative bacteria
KR20170107423A (ko) 접근 보존 전위
WO2018005117A1 (en) Storage through iterative dna editing
JP2002520074A (ja) シス作用性核酸エレメントおよび使用法
Ikeda et al. DNA polymerase IV mediates efficient and quick recovery of replication forks stalled at N2-dG adducts
Chambers et al. A DNA translocation motif in the bacterial transcription–repair coupling factor, Mfd
CN105859829A (zh) 纯化或检测靶蛋白的方法
JP2004525618A5 (enExample)
Amundsen et al. The RecB helicase-nuclease tether mediates Chi hotspot control of RecBCD enzyme
Ge et al. Non‐stop mRNA decay initiates at the ribosome
Chen et al. Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA
Li et al. Hjm/Hel308A DNA helicase from Sulfolobus tokodaii promotes replication fork regression and interacts with Hjc endonuclease in vitro
Sutormin et al. Single-nucleotide resolution detection of Topo IV cleavage activity in the Escherichia coli genome with Topo-Seq
Mitchener et al. Janus bioparticles: asymmetric nucleosomes and their preparation using chemical biology approaches
Lang et al. Common requirement for the relaxosome of plasmid R1 in multiple activities of the conjugative type IV secretion system
Brinkman et al. Interactions of the energy transducer TonB with noncognate energy-harvesting complexes
Neilson et al. Site‐specific recombination at dif by Haemophilus influenzae XerC